Compass Therapeutics EPS CMPX

Diluted earnings per share by quarter and over the last twelve months, from 2018.

Compass Therapeutics' twelve-month earnings per share can't be added up yet: a quarter of its results is missing from our data.

In its latest quarter, Q1 FY25, it was −$0.12.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q1 FY25	Mar 31, 2025	−$0.12	n/a	n/a
Q4 FY24	Dec 31, 2024	−$0.11	n/a	n/a
Q3 FY24	Sep 30, 2024	−$0.08	n/a	n/a
Q1 FY22	Mar 31, 2022	−$0.07	n/a	−$1.39
Q4 FY21	Dec 31, 2021	−$0.15	n/a	−$1.46
Q3 FY21	Sep 30, 2021	−$0.10	n/a	−$1.47
Q2 FY21	Jun 30, 2021	−$1.07	n/a	−$1.55
Q1 FY21	Mar 31, 2021	−$0.14	n/a	−$0.89
Q4 FY20	Dec 31, 2020	−$0.16	n/a	−$1.65
Q3 FY20	Sep 30, 2020	−$0.18	n/a	−$1.49
Q1 FY20	Jun 30, 2020	−$0.41	n/a	−$2.58
Q4 FY20	Mar 31, 2020	−$0.90	n/a	−$3.50

Companies in Healthcare nearest Compass Therapeutics' size, closest first, today.

Company	EPS, 12 months	Growth
CMPXCompass Therapeutics	n/m
KEQUKewaunee Scientific	$2.76	−33% a year
PDEXPro DEX	$4.11	+52% a year
ICCCImmucell	$0.08	−58% a year
PLXProtalix BioTherapeutics	$0.23	+283% a year
NATRNatures Sunshine Products	$1.01	+36% a year
ELMDElectromed	$1.31	+56% a year
UTMDUtah Medical Products	$3.28	−12% a year
LFVNLifevantage	$0.40	−46% a year
INFUInfuSystem	$0.41	+78% a year
SPROSpero Therapeutics	$0.11
Peer median	$0.71